Skip to main navigation Skip to search Skip to main content

Evidence for assessing drug safety and drug use in older people

Luciane Cruz Lopes, Ria Benko, Marcio Galvão Oliveira, Vera Maria Vieira Paniz, Brian Godman, Fabiane Raquel Motter

Research output: Contribution to journalEditorialpeer-review

38 Downloads (Pure)

Abstract

Prescribing for older patients presents several challenges. Older people often suffer from two or more chronic diseases (multimorbidity) and therefore use a greater number of medications compared to other age groups. As a result, they are more susceptible polypharmacy, and associated drug-related problems, including potentially inappropriate medication (PIM), drug ineffectiveness, drug interactions, and adverse drug events (Nobili et al., 2011; Aggarwal et al., 2020). Consequently, optimizing drug therapy is a crucial part of caring for an elderly individual. This is increasingly important given the rising number of elderlies across countries in the coming years, with one in 6 of the world’s population over 60 by 2050 and the associated resource implications (World Health Organization, 2021).
Original languageEnglish
Article number941813
Number of pages6
JournalFrontiers in Pharmacology
Volume13
DOIs
Publication statusPublished - 1 Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • elderly
  • drug safety
  • assessment
  • health policy

Fingerprint

Dive into the research topics of 'Evidence for assessing drug safety and drug use in older people'. Together they form a unique fingerprint.

Cite this